1. GGNBP2 suppresses triple-negative breast cancer aggressiveness through inhibition of IL-6/STAT3 signaling activation
    Jingjing Liu et al, 2019, Breast Cancer Research and Treatment CrossRef
  2. Discovery of microarray-identified genes associated with ovarian cancer progression
    XIA LIU et al, 2015, International Journal of Oncology CrossRef
  3. Ggnbp2-Null Mutation in Mice Leads to Male Infertility due to a Defect at the Spermiogenesis Stage
    Lingyun Liu et al, 2017, The American Journal of Pathology CrossRef
  4. Effects of gametogenetin‐binding protein 2 on proliferation, invasion and migration of prostate cancer PC‐3 cells
    Zhangjie Yang et al, 2020, Andrologia CrossRef
  5. Bibliometric and visualized analysis of drug resistance in ovarian cancer from 2013 to 2022
    Jiahua Liu et al, 2023, Frontiers in Oncology CrossRef
  6. GGNBP2 regulates histone ubiquitination and methylation in spermatogenesis
    Kaimin Guo et al, 2024, Epigenetics CrossRef
  7. Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis
    Antonino Bruno et al, 2022, International Journal of Molecular Sciences CrossRef
  8. GGNBP2 acts as a tumor suppressor by inhibiting estrogen receptor α activity in breast cancer cells
    Zi-Jian Lan et al, 2016, Breast Cancer Research and Treatment CrossRef
  9. Expression of integrin α‑6 is associated with multi drug resistance and prognosis in ovarian cancer
    Luwei Wei et al, 2019, Oncology Letters CrossRef
  10. Downregulation of transient receptor potential cation channel, subfamily C, member 1 contributes to drug resistance and high histological grade in ovarian cancer
    XIA LIU et al, 2016, International Journal of Oncology CrossRef
  11. Low expression of KCNN3 may affect drug resistance in ovarian cancer
    Xia Liu et al, 2018, Molecular Medicine Reports CrossRef
  12. Expression, Location, Clinical Implication, and Bioinformatics Analysis of RNASET2 in Gastric Adenocarcinoma
    Zhi Zeng et al, 2020, Frontiers in Oncology CrossRef
  13. Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
    Francesca Roggiani et al, 2016, International Journal of Molecular Sciences CrossRef
  14. GGNBP2 is necessary for testis morphology and sperm development
    Anqi Chen et al, 2017, Scientific Reports CrossRef
  15. Ablation of Ggnbp2 impairs meiotic DNA double‐strand break repair during spermatogenesis in mice
    Kaimin Guo et al, 2018, Journal of Cellular and Molecular Medicine CrossRef
  16. Cross-validation of genes potentially associated with overall survival and drug resistance in ovarian cancer
    Yutao Gao et al, 2017, Oncology Reports CrossRef
  17. HIF2α‐induced upregulation of RNASET2 promotes triglyceride synthesis and enhances cell migration in clear cell renal cell carcinoma
    Yanmei Quan et al, 2023, FEBS Open Bio CrossRef
  18. GGN Promotes Tumorigenesis by Regulating Proliferation and Apoptosis in Colorectal Cancer
    Zheng Liu et al, 2019, Pathology & Oncology Research CrossRef
  19. Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation
    Qi Wang et al, 2022, Oncogene CrossRef
  20. The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy
    Paola Campomenosi et al, 2023, Biomedicines CrossRef